King Pharmaceuticals, Painkiller Maker, Being Obtained

King Pharmaceuticals has approved an offer from Pfizer to merge. This will put the number of pharma mergers this year to an unprecedented number. King Pharmaceuticals will definitely cost Pfizer over $ 3.5 billion, making it the second largest purchase ever by the world’s largest drug company. The blended business is intended to fight off losing income that takes place when patents expire.

Pay out the premium for King Pharmaceuticals

King Pharmaceuticals was declared to be bought by Pfizer. When this statement had been made, King’s current stock price was 40 % lower than the price being paid. King’s price jumped to match the offer in trading on Mon. King Pharmaceuticals mostly manufacturers pain medicine, which Pfizer clearly thought was significant. The entire portfolio of King Pharmaceuticals drugs can be rolled into Pfizer’s manufacturing and marketing divisions.

Creating a portfolio useful for Pfizer

Pain medication is what King Pharmaceuticals specializes in. This mostly what is made by it. King has been long developing “abuse-resistant” pain medication intended to replace drugs such as OxyContin. The EpiPen and vet drugs are made by King Pharmaceuticals. Also, a contract is already set between the Department of Defense and King Pharmaceuticals where pre-filled syringes of anti-nerve agent medication are made. These contracts could be merged at the very same time Pfizer and King merge their operations.

Figuring out difficulties with patent between Pfizer and King

Mergers and buyouts have took place before. This isn’t the first. Buyouts have made Pfizer a much larger business. It is the largest drug maker in the world in fact. Pfzier, also as King Pharmaceuticals, faces a severe income problem in what the industry refers to as the “patent cliff.”. Anytime a drug comes to the industry, it gets a patent. This protects it at first. Generic versions of the drugs can’t be manufactured until the patent expires. Pfizer’s best-selling drug, Lipitor, faces a 60 percent drop in its several-hundred million dollar a year sales when it falls off the patent cliff. The hope is the purchase of King Pharmaceuticals and its drug portfolio will help make up for this loss of income.

Citations

Associated Press

google.com/hostednews/ap/article/ALeqM5hbaoWbl-qz6f2UkSXhOhVLnVHFrwD9IQB2C01?docId=D9IQB2C01

NY Times

dealbook.blogs.nytimes.com/2010/10/12/pfizer-to-buy-king-pharmaceuticals-for-3-6-billion/

Tags: best french press maker, press make readies, press maker, press maker machine, press makeready

This entry was posted on Thursday, January 19th, 2012 at 5:26 am and is filed under Kitchen. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.